GSK (LON:GSK) Stock Passes Above 200 Day Moving Average - Here's What Happened

Key Points

• GSK shares have crossed above their 200-day moving average for the first time in recent trading, indicating potential bullish sentiment.
• Research analysts have differing views on GSK, with one rating it a Buy, two issuing a Hold rating, and one suggesting a Sell.
• The stock recently reported a market capitalization of £60.27 billion and a P/E ratio of 1,809.55, raising potential concerns about valuation.

GSK plc (LON:GSK - Get Free Report) shares crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 1,432.77 ($19.30) and traded as high as GBX 1,506 ($20.29). GSK shares last traded at GBX 1,496.50 ($20.16), with a volume of 12,458,038 shares traded.

Analysts Set New Price Targets

A number of research firms have recently commented on GSK. JPMorgan Chase & Co. dropped their price target on GSK from GBX 1,460 to GBX 1,400 and set an "underweight" rating on the stock in a research report on Monday, August 4th. Deutsche Bank Aktiengesellschaft reaffirmed a "hold" rating and set a GBX 1,450 price target on shares of GSK in a research report on Thursday, July 31st. Berenberg Bank reaffirmed a "hold" rating and set a GBX 1,600 price target on shares of GSK in a research report on Friday, July 18th. Finally, Shore Capital reaffirmed a "buy" rating and set a GBX 2,100 price target on shares of GSK in a research report on Wednesday, August 27th. One equities research analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of GBX 1,637.50.

GSK Price Performance

The stock has a market cap of £60.27 billion, a price-to-earnings ratio of 1,809.55, a price-to-earnings-growth ratio of 1.24 and a beta of 0.31. The company has a 50-day simple moving average of GBX 1,434.90 and a two-hundred day simple moving average of GBX 1,432.42. The company has a debt-to-equity ratio of 114.64, a quick ratio of 0.73 and a current ratio of 0.81.

GSK (LON:GSK - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The company reported GBX 75.30 earnings per share for the quarter. GSK had a return on equity of 18.08% and a net margin of 8.02%. As a group, equities research analysts forecast that GSK plc will post 175.980975 EPS for the current year.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.